Exploring women's experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer.

ABSTRACT:

Background

Some women with operable breast cancer have a choice between receiving upfront surgery followed by chemotherapy or neoadjuvant systemic therapy (NAST) prior to receiving surgery. While survival outcomes are equivalent for both options, the decision about treatment sequence can be difficult due to its complexity and perceived urgency. A decision aid has been developed to help patients decide on whether to receive NAST.

Aims

To explore, qualitatively, women's use and perceived benefit of a decision aid to help with their decision on NAST.

Methods

A framework analysis process was conducted on a purposeful sample of 20, one-on-one, semistructured phone interviews with early-stage breast cancer patients eligible for NAST. Participants had recently decided on whe

SUBMITTER: Herrmann A 

PROVIDER: S-EPMC6266373 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature